Adediran EO. Pefloxacin and its derivative, novel inhibitors of the SARS-CoV-2 Main protease (3CLpro) and their pharmacokinetics prediction: An in silico analysis. Arch Pharm Pharma Sci [Internet]. 2022 Jun. 12 [cited 2025 Dec. 7];6(1):013-8. Available from: https://www.pharmacyscijournal.com/index.php/apps/article/view/apps-aid1030